ExodusPoint Capital Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.44M Buy
126,515
+62,174
+97% +$4.64M 0.08% 220
2025
Q1
$4.09M Buy
64,341
+49,898
+345% +$3.17M 0.04% 439
2024
Q4
$1.13M Sell
14,443
-66,500
-82% -$5.19M 0.01% 834
2024
Q3
$6.51M Buy
80,943
+51,667
+176% +$4.15M 0.04% 288
2024
Q2
$2.42M Buy
+29,276
New +$2.42M 0.02% 607
2023
Q3
Sell
-10,423
Closed -$887K 1803
2023
Q2
$887K Sell
10,423
-39,809
-79% -$3.39M 0.01% 1061
2023
Q1
$4.16M Buy
50,232
+12,332
+33% +$1.02M 0.03% 496
2022
Q4
$2.98M Buy
+37,900
New +$2.98M 0.04% 484
2022
Q1
Sell
-5,726
Closed -$304K 2303
2021
Q4
$304K Buy
+5,726
New +$304K ﹤0.01% 1615
2021
Q2
Sell
-6,015
Closed -$668K 2450
2021
Q1
$668K Sell
6,015
-32,473
-84% -$3.61M 0.01% 1120
2020
Q4
$4.57M Sell
38,488
-14,171
-27% -$1.68M 0.04% 253
2020
Q3
$4.59M Buy
52,659
+14,258
+37% +$1.24M 0.09% 165
2020
Q2
$3.44M Buy
+38,401
New +$3.44M 0.09% 239
2020
Q1
Sell
-33,437
Closed -$3.84M 1250
2019
Q4
$3.84M Buy
+33,437
New +$3.84M 0.07% 165